Fundraising FoxClal Biotechnology Industries — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Cadenttxcadenttx.comin𝕏Nov 2018acquired by Novartis
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsQiming Venture Partners USASlater Technology FundAccess IndustriesAtlas VentureCowen Healthcare InvestmentsNovartis Institute for Biomedical Research+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.